Показать сокращенную информацию
dc.contributor.author | Arustamyan G. | |
dc.contributor.author | Yegorov E. | |
dc.contributor.author | Lipsky S. | |
dc.contributor.author | Razumovskaya E. | |
dc.contributor.author | Gimranova L. | |
dc.date.accessioned | 2018-09-18T20:26:37Z | |
dc.date.available | 2018-09-18T20:26:37Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 1818-4952 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/139930 | |
dc.description.abstract | The increasing costs of public health and a growing demand for high-level medicine require the development of efficient economic methods of evaluation and quality management. This article proves that the Clinical and Economic Analysis (C&EA) is the most efficient in terms of cost-benefits. Furthermore, the article defines the role of C&EA by using the principles of evidence-based medicine. A comparative study of the Russian and European experience of C&EA is carried out, with an emphasis on Russian healthcare problems. The article concludes that a modernized C&EA methodology should be introduced, taking into account the European - particularly the French - model of healthcare. © IDOSI Publications, 2013. | |
dc.relation.ispartofseries | World Applied Sciences Journal | |
dc.subject | Clinical and economic Analysishealthcare quality | |
dc.subject | Comparative efficiency | |
dc.subject | Efficiency evaluation methods | |
dc.subject | Medical and economic standards | |
dc.subject | Quality management | |
dc.title | Clinical and economic analysis and its role in healthcare quality management | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 3 | |
dc.relation.ispartofseries-volume | 27 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 318 | |
dc.source.id | SCOPUS18184952-2013-27-3-SID84890337464 |